Previous Close | 1.4200 |
Open | 1.3126 |
Bid | 1.3100 x 1800 |
Ask | 1.5300 x 900 |
Day's Range | 1.3000 - 1.3126 |
52 Week Range | 1.2700 - 13.0100 |
Volume | |
Avg. Volume | 12,344 |
Market Cap | 23.367M |
Beta (5Y Monthly) | 1.36 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.5130 |
Earnings Date | May 13, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.00 |
TORONTO, June 27, 2022--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today an update on the status of its previously-announced proposed acquisition (the "Acquisition") of Check Five LLC, a Delaware limited liability company (doing business as "Success TMS") ("Success TMS"). Greenbrook and Success TMS continue to work diligently towards closing the Acquisition
TORONTO, June 21, 2022--Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook
TORONTO, June 01, 2022--Greenbrook TMS Inc. (TSX: GTMS) ("Greenbrook" or the "Company") is pleased to announce that it will host a webcast investor presentation on Tuesday, June 7th, 2022, at 2:00 PM ET.